Novartis Ophthalmics
  Novartis Pharma US

 
CHANGE TEXT SIZE  Decrease Font Size Increase Font Size
Helpful Hints
Help your patients understand how their eyes work, how to care for their eyes, their children's eyes, and what tests they may receive during an eye exam.
Find Out How >

Advancing Excellence in Ophthalmology

Voltaren Ophthalmic® (diclofenac sodium ophthalmic solution) 0.1%



Voltaren Ophthalmic® 
(diclofenac sodium 
ophthalmic solution) 0.1%

Voltaren Ophthalmic is a nonsteroidal anti-inflammatory drug for treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery.

Diclofenac sodium, the principal active ingredient of Voltaren Ophthalmic, is a phenylacetic acid that has analgesic and anti-inflammatory activity. It is believed to act through the reversible inhibition of the cyclo-oxygenase enzymes COX-1 and COX-2 that are essential in the biosynthesis of prostaglandins.

Dosage Information

The typical dosing is as follows:
  • For cataract surgery: the patient should administer 1 drop of Voltaren Ophthalmic to the affected eye 4 times daily beginning 24 hours after cataract surgery and continuing throughout the first 2 weeks after surgery.
  • For corneal refractive surgery: the patient should apply 1 or 2 drops to the eye that will be surgically treated within the hour before surgery. Within 15 minutes after surgery, 1 to 2 drops of Voltaren Ophthalmic should be instilled into the eye. Administration should be continued 4 times daily for up to 3 days.

Back to Top


Voltaren Ophthalmic® 
(diclofenac sodium 
ophthalmic solution) 0.1%

Voltaren Ophthalmic® Safety Information
EYE DISEASES & DISORDERS
Facts on specific eye diseases
Read More >



Home  |  Professional Main Page  |  About Ophthalmics  |  Products
Eye Diseases & Disorders  |  Patient Education Library
Patient Assistance Program  |  Press Releases

Contact Us  |  Site Guide  |  Site Map

Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2007
Novartis Pharmaceuticals Corporation. All rights reserved.